A caregiver's all-too-familiar narrative - "He doesn't think through what he does, but mostly he does nothing." Apathy and impulsivity, debilitating and poorly understood, commonly co-occur in Huntington's disease (HD). HD is a neurodegenerative disease with manifestations bridging clinical neurology and psychiatry. In addition to movement and cognitive symptoms, neurobehavioral disturbances, particularly apathy and impulsivity, are prevalent features of HD, occurring early in the disease course, often worsening with disease progression, and substantially reducing quality of life. Treatments remain limited, in part because of limited mechanistic understanding of these behavioral disturbances. However, emerging work within the field of decision-making neuroscience and beyond points to common neurobiological mechanisms underpinning these seemingly disparate problems. These insights bridge the gap between underlying disease pathology and clinical phenotype, offering new treatment strategies, novel behavioral and physiological biomarkers of HD, and deeper understanding of human behavior. In this review, we apply the neurobiological framework of cost-benefit decision making to the problems of apathy and impulsivity in HD. Through this decision-making lens, we develop a mechanistic model that elucidates the occurrence of these behavioral disturbances and points to potential treatment strategies and crucial research priorities. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322688PMC
http://dx.doi.org/10.1002/mds.29013DOI Listing

Publication Analysis

Top Keywords

apathy impulsivity
16
decision making
8
huntington's disease
8
behavioral disturbances
8
treatment strategies
8
disease
6
disordered decision
4
making cognitive
4
cognitive framework
4
apathy
4

Similar Publications

Background: Effects of subthalamic nucleus deep brain stimulation (STN-DBS) on neuropsychiatric symptoms of Parkinson's disease (PD) remain debated. Sensor technology might help to objectively assess behavioural changes after STN-DBS.

Case Presentation: 5 PD patients were assessed 1 before and 5 months after STN-DBS with the Movement Disorders Society Unified Parkinson's Disease Rating Scale part III in the medication ON (plus postoperatively stimulation ON) condition, the Montreal Cognitive Assessment, the Questionnaire for Impulsive-Compulsive Behaviors in Parkinson's Disease Rating Scale present version, the Hospital Anxiety and Depression Scale and the Starkstein Apathy Scale.

View Article and Find Full Text PDF

Background: Impulse control disorders (ICD) are common side effects of dopaminergic treatment in Parkinson's disease (PD). Whereas some studies show a reduction in ICD after subthalamic nucleus deep brain stimulation (STN-DBS), others report worsening of ICD or impulsivity.

Objective: The aim was to study ICD in the context of STN-DBS using an objective measure of decision-making.

View Article and Find Full Text PDF

Psychiatric and cognitive symptoms of Parkinson's disease: A life's tale.

Rev Neurol (Paris)

December 2024

Department of Neurology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland.

Introduction: Neuropsychiatric symptoms are highly prevalent in Parkinson's disease (PD) and significantly affect the quality of life of patients and their significant others. The aim of this work is to describe typical neuropsychiatric symptoms and their treatment.

Methods: This is a narrative opinion paper, illustrated by a fictional case report.

View Article and Find Full Text PDF

The three clap test: a window into cognitive and frontal lobe dysfunction.

Neurol Sci

November 2024

Parkinsonism and Movement Disorders Treatment Center, Zvolen Hospital, Zvolen, Slovakia.

Article Synopsis
  • The three clap test (TCT) is a quick bedside assessment that can reveal the applause sign (AS), which is characterized by patients clapping more than three times when asked to clap just three times.
  • The AS helps distinguish between various neurological conditions, including progressive supranuclear palsy (PSP) and Parkinson's disease (PD), but can also appear in other conditions like Alzheimer's disease and frontotemporal dementia (FTD).
  • The TCT can reveal additional behaviors, such as the non-applause sign linked to apathy in FTD and the jumping the gun sign indicating impulsivity in PSP, highlighting its value in clinical practice for assessing cognitive functions and behaviors.
View Article and Find Full Text PDF

Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET.

Neurol Sci

November 2024

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.

Objectives: Neuropsychiatric symptoms, such as apathy, disinhibition and irritability, are common in Progressive Supranuclear Palsy (PSP). The Frontal Behaviour Inventory (FBI) is a useful instrument for the evaluation of behavioural disorders in neurodegenerative diseases. The main goal of the present study was to explore the psychometric properties of the FBI in PSP.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!